GleamWall
中文EN

OSUR ORASURE TECHNOLOGIES INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1116463 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-7.5%
TTM net income YoY19.5%
TTM EPS YoY14.8%
Revenue 3-yr CAGR-36.4%
Net income 3-yr CAGR—

Margins

Gross margin43.1%
Operating margin-43.8%
Net margin-41.7%
FCF margin-42.7%
EBITDA margin-35.8%

Returns

ROE-14.5%
ROA-12.6%
ROIC (approx.)-26.4%
Asset turnover0.30x

Leverage & solvency

Liabilities / assets12.1%
Debt / equity0.00x
Current ratio8.58x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-1.2%
Payout ratio—
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$30.91M$30.64M$27.93M$26.76M$27.09M$31.24M$29.93M$37.45M
Cost of revenue$16.94M$17.32M$16.12M$15.79M$15.31M$18.08M$17.63M$23.88M
Gross profit$13.97M$13.32M$11.80M$10.97M$11.77M$13.16M$12.30M$13.57M
R&D expense$7.63M$9.44M$13.65M$11.42M$10.11M$11.40M$9.60M$6.09M
SG&A expense$11.99M$14.43M$14.56M$9.82M$11.08M$12.68M$14.10M$12.90M
Operating income-$12.96M$5.44M-$23.27M-$20.10M-$16.09M-$18.03M-$17.75M-$12.42M
Pretax income-$11.79M$6.82M-$21.72M-$18.43M-$13.29M-$16.89M-$15.97M-$9.51M
Income tax$708,000$55,000-$432,000$210,000$47,000$2.00M-$456,000$758,000
Net income-$13.09M$6.25M-$22.38M-$19.29M-$13.71M-$19.69M-$16.04M-$10.79M
EBITDA-$10.76M$7.81M-$20.93M-$17.70M-$13.64M-$15.50M-$14.94M-$9.93M
EPS (basic)-0.190.09-0.32—-0.19-0.26-0.21—
EPS (diluted)-0.190.09-0.32—-0.19-0.26-0.21—
Weighted avg. shares (diluted)69.00M70.16M69.67M—73.00M74.54M74.87M—
Balance sheet
Cash & equivalents$148.24M$160.58M$176.96M$199.28M$216.48M$234.58M$247.57M$267.76M
Receivables$30.42M$25.60M$24.81M$22.20M$24.30M$25.90M$21.52M$23.82M
Inventory$30.42M$30.07M$30.31M$31.06M$33.40M$33.38M$35.68M$34.20M
Current assets$215.29M$222.94M$240.78M$261.91M$283.01M$301.44M$313.78M$333.22M
PP&E, net$36.51M$38.58M$37.86M$39.18M$40.80M$42.16M$43.16M$45.10M
Goodwill$42.74M$42.72M$43.05M$43.36M$41.31M$41.74M$40.45M$40.33M
Intangibles$18.76M$18.84M$18.94M$19.05M$17.20M$17.27M$17.31M$17.43M
Total assets$349.47M$360.55M$379.17M$403.17M$423.10M$445.04M$457.61M$479.66M
Current liabilities$25.10M$25.12M$44.08M$39.80M$40.25M$42.35M$25.42M$33.48M
Total liabilities$42.33M$42.77M$65.84M$62.34M$61.12M$64.31M$61.33M$69.32M
Shareholders' equity$307.13M$317.78M$313.32M$340.83M$361.98M$380.72M$396.28M$410.34M
Shares outstanding69.04M68.97M69.40M70.39M72.27M73.73M75.11M74.60M
Cash flow statement
Operating cash flow-$10.87M-$9.92M-$13.89M-$9.00M-$10.07M-$10.22M-$19.73M$109,000
Capital expenditure$1.67M$2.43M$913,000$922,000$919,000$1.94M$420,000$456,000
Free cash flow-$12.55M-$12.35M-$14.81M-$9.92M-$10.99M-$12.16M-$20.15M-$347,000
Investing cash flow-$1.67M-$2.41M-$913,000-$4.42M-$821,000-$1.94M$370,000-$5.49M
Financing cash flow-$35,000-$2.25M-$6.28M-$5.11M-$5.08M-$5.80M-$953,000-$111,000
Depreciation & amortization$2.20M$2.37M$2.34M$2.40M$2.45M$2.53M$2.81M$2.49M
Stock-based compensation$2.28M$2.29M$2.77M$1.46M$2.83M$3.17M$2.69M$2.74M
Share buybacks$0$2.00M$5.00M$5.04M$5.00M$4.06M$0$0

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.